Plaque Characteristics in Coronary Artery Disease. Chourmouzios Arampatzis MD, PhD, FESC
|
|
- Milton Wilkins
- 5 years ago
- Views:
Transcription
1 Plaque Characteristics in Coronary Artery Disease Chourmouzios Arampatzis MD, PhD, FESC
2 Disclosure Statement of Financial Interest Regarding this Presentation NONE
3 Atherosclerosis Model proposed by Stary I II III IV V VI The initial knowledge of atherosclerosis progression was reported in the early 1980s without however understand the relation between lesion progression and ACS. The numeric AHA classification (1994) incomplete described the diversity of human CAD. Adaptive thickening of SMC Macrophage foam cells Standard atherosclerosis development Pools of Internal core Fibrous extracellular of extracellular thickening lipids lipids Complicated lesion Stary et al, Arterioscler Thromb Vasc Biol 1992;12: Lipid accumulation Calcification Hyperplasia Thrombosis hematoma
4 Current Concepts of Atherosclerosis In the modified classification the numeric AHA types I-IV are replaced by descriptive terminology: adaptive intimal thickening, intimal xanthoma (fatty streak), pathologic intimal thickening, and fibroatheroma. Lesions alluded to in types V and VI were discarded since they failed to account for the three different causes of thrombotic morphologies (rupture, erosion and calcified nodule) and their relationship to healed plaque that is representative of stable angina. Type I Type II Type III Type IV Adaptive intimal thickening Intimal xanthoma Pathologic intimal thickening Fibrous cap atheroma Thin-cap fibroatheroma Virmani et al, Arterioscler Thromb Vasc Biol 2000;20:
5 Nonatherosclerotic intimal lesions Progressive atherosclerotic lesions Artery wall Lumen Intimal thickening Intimal xanthoma Pathological intimal thickening Without With macrophage macrophage Early Fibroatheroma Late Thin cap fibroatheroma Smooth muscle cells Macrophage foam cells Extracellular lipid Collagen Necrotic core Cholesterol clefts Calcified plaque Rupture Lesions with acute thrombi Underlying PIT Erosion Calcified nodule Plaque fissure Fibrous plaque Underlying fibroatheroma Angiogenesis Hemorrhage Fibrin Complications of hemorrhage and/or thrombus with healing and stabilization Thrombus Intraplaque hemorrhage Single layer Healed Rupture Multiple layers CTO Fibrocalcific plaque Nodular calcification Healed thrombus Adapted from Nature 2015
6 Arampatzis et al, Circulation 2003;108:34-35 TOMTEC Surgical View
7 Sudden Coronary Death Calcified nodules Erosion 30-40% ACS 50-75% Plaque rupture 60-75% 2-7% 70% remote TCFA Stable CAD 25-50% 30% TCFA 18% TCFA 20% TCFA 43% TCFA 61% of SCD victims show at least one healed plaque rupture lesion, in which the incidence is greatest in the deaths from stable angina with severe stenosis (80%), followed by acute plaque rupture (75%) and the least in plaque erosions. In Coronary Atheroslerosis Arampatzis et al Taylor & Francis 2012
8 Coronary Artery Disease is Changing STEMI plaque rupture erosion Plaque erosion Lipid poor Proteoglycan and glycosaminoglycan rich Non-fibrillar collagen breakdown Few inflammatory cells Endothelial cell apoptosis Secondary neutrophil involvement Female predominance High triglycerides Libby Eur Heart J 2015;43: Plaque rupture Lipid rich Collagen poor, thin fibrous cap Interstitial collagen breakdown Abundant inflammation Smooth muscle cell apoptosis Macrophage predominance Male predominance High LDL NSTEMI plaque rupture erosion
9 Narula et al. J Am Coll Cardiol 2013;61:
10 Image Angiography Grayscale IVUS VH-IVUS Angioscopy OCT IVPA/US Images of blood flow Tomogram Tomogram Surface imaging only Sub-surface tomogram Tomogram Axial resolution Type of radiation X-ray Ultrasound Ultrasound Visible light Near IR light Near IR light + US Lumen area Plaque burden Positive remodeling Necrotic core - ± ++ ± - ++ Fibrous cap thickness - - ± ± ++ ± TCFA - - ± ± ++ ± Plaque rupture ± Erosion Thrombus ± ± ± ++ + ±
11 Boston Atlantis SR 30MHz Ruptured plaque with lipid rich necrotic core Fibrous plaque with deep calcification Fibrofatty plaque with deep attenuation Volcano Revolution TM 45MHz Intraluminal thrombus Fibrous plaque Calcified plaque In Coronary Atheroslerosis Arampatzis et al Taylor & Francis 2012
12 A. Virtual Histology employs spectral radiofrequency analyses with a classification tree algorithm developed from ex-vivo datasets, showing distinct color for each of the fibrous, fibro-fatty, necrotic core and calcific components. B. Integrated Backscatter IVUS utilizes backscatter values, calculated as the average power of the backscattered ultrasound signals from a sample tissue volume, to differentiate tissue types: fibrosis, dense fibrous, lipid pool and calcification. C. imap identifies 4 different types of plaque components (fibrotic, lipidic, necrotic and calcified tissue) based on the degree of spectral similarity between the backscattered signal and a reference library of spectra from known tissue types.
13 Pathological intimal thickening (PIT) is considered as a progressive lesion in the early stages of atherosclerosis and represents a precursor lesion to fibroatheroma. It consists of mainly a mixture of fibrotic tissue and fibrofatty plaque with less than 10% each confluent necrotic core and dense calcium respectively. Thin-cap fibroatheroma (TCFA) has been considered as a high-risk lesion causing ACS. Histologically, TCFA is characterized by thin cap overlying a large necrotic core containing numerous cholesterol clefts. On VH, TCFA is characterized as having more than 10% necrotic core,no evidence of fibrous cap and less than 10% of calcium. Thick-cap fibroatheroma (ThCFA) harbors a large lipid-necrotic core comprising large amount of extracellular lipid, cholesterol crystals and necrotic debris, surrounded by a thick fibrous cap. The definition of ThCFA is a lesion with more than 10% confluent necrotic core and a definable fibrous cap. VH-IVUS derived fibrotic plaque is mainly fibrous tissue without confluent necrotic core or calcium. Fibrotic plaque is different from PIT with regard to the presence of fibro-fatty tissue. Fibrotic plaque contains few fibro-fatty tissue (<15%), whereas PIT contains >15% fibro-fatty tissue. Fibrocalcific plaque is a collagen rich lesion with nearly all fibrotic tissue and dense calcium with less than 10% confluent necrotic core. Garcia-Garcia HM, Eurointervention 2009;5:177-89
14 Lessons from the PROSPECT-lesion related factors Independent predictors of lesion level events by Cox proportional Hazards reduction Model Events VS number of high risk factors 18.2 Variable HR (95%CI) P PB MLA 70% 5.03( ) < VH-TCFA 3.35( ) MLA<4mm ( ) Zero One Two Three 5/ / /253 5/29 Stone et al, N Engl J Med 2011;364:226-35
15 Remodeling Proximal Distal Positive remodeling in response to plaque growth helps to prevent luminal narrowing. However Larger lipid core and a greater macrophage burden. More unstable clinical presentation. More CPK elevation after PCI. No reflow in primary PCI. Recurrent ischemia within 1 month after thrombolysis. More TLR. More MACE in patients with UA and any form of revascularization. More intimal hypeprlasia. More in-hospital complications in patients with stable CAD undergoing single vessel PCI. + - Proximal Distal In Coronary Atheroslerosis Arampatzis et al Taylor & Francis 2012
16 Non-culprit MACE (%) Remodeling-Insights from the PROSPECT Trial 697 pts with 3223 NCLs Positive Remodeling Negative Remodeling 2.5% 2.1% 0.7% HR 95% CI p-value RI<0.88 vs RI ( ) RI>1.00 vs RI ( ) Plaque burden >70% 5.03 ( ) < VH TCFA 3.05 ( ) MLA<4mm ( ) Intermediate Remodeling Plaques with negative remodeling were associated with longer and more calcified lesions and more severe stenosis. In addition they had the greatest frequency of VH-TCFA with multiple NCs. The presence of NCs was consistent with more advanced atherosclerosis in which there has been a recurring cycle of rupture and healing. Thus negative remodeling is sometimes a marker of more advanced atherosclerosis. Inaba et al. JACC Cardiovasc Imaging 2014;7:70-8
17 Lessons from the PROSPECT-progression of fibroatheromas Distance from ostium to max NC site, per 10mm Odds Ratio 95% CI P value Mean external elastic < membrane area, per mm 2 Mean plaque burden, per 10% < Calcium < RCA Plaque rupture was associated with large vessel area, greater plaque burden and proximal location within nonculprit coronary arteries. However EEM area was the strongest predictor for plaque rupture in the LAD, LCx and RCA while plaque burden seemed to be the most important risk factor for plaque rupture in the LMCA Zheng et al 2015;8: EEM integrates vessel area, plaque burden and remodeling
18 Non-Invasive Imaging Apart from being a gate keeper for CAG, one of the most appealing features of CCTA is the ability to look beyond luminal stenosis and provide a detailed evaluation of the coronary wall depicting several features like plaque composition (calcified, non-calcified, mixed), plaque burden, remodeling index and degree of attenuation (HU). Spotty calcification, positive remodeling and low attenuation
19 Plaque Characteristics with CCTA Plaque composition Non-calcified Partially calcified Calcified High risk plaque features Low attenuation Spotty calcification Positive remodeling Plaque attenuation pattern Napkin-ring sign Heterogeneous Homogenous
20 The CONFIRM multicenter observational registry All Cause Mortality Composite (death/mi) 7590pts without chest pain and without known CAD Cho et al, Circulation 2012;126:304-13
21 The CONFIRM multicenter observational registry C-Statistics Model FRS Individual Risk Factors All-cause mortality (n=3900) Model I: RFs only 0.62( ) 0.76 ( ) Model II: RFs+CACS 0.71( ) 0.78( ) Model III: RFs+CACS+NIV 0.73( ) 0.78( ) Model IV: RFs+CACS+Duke 0.72( ) 0.78( ) Model V: RFs+CACS+SSS 0.72( ) 0.78( ) Model VI: RFs+CACS+SIS 0.72( ) 0.78( ) Cho et al, Circulation 2012;126:304-13
22 Lessons from the CONFIRM Adjusted survival probability Mixed or calcified plaques Stenosis > 50% No proximal segment No proximal segment One or more proximal segments One or more proximal segments Two or more proximal segments Two or more proximal segments Deseive et al Eur Heart J Cardiovasc Imaging 2017;18:286-93
23 CCTA with FFR Incremental risk prediction Global χ 2 252pts 407 lesions with clinically indicated CAG 50% CT Sten 50% CT Sten +SC 50% CT Sten +SC+LAP 50% CT Sten +SC+LAP+PR 50% CT Sten +SC+LAP +PR+ %APV Park et al JACC Cardiovasc Imaging 2015;8:1-10
24 CCTA with FFR multivariate analysis of APCs Obstructive lesions ( 50%) Model 1 OR (95% CI) p Lumen area stenosis (per 5%) 1.10 ( ) 0.07 Lesion length 1.03 ( ) 0.01 PR 3.60 ( ) <0.001 LAP 2.50 ( ) SC 1.40 ( ) 0.42 Model 2 Lumen area stenosis (per 5%) 1.10 ( ) 0.12 % APV (per 5%) 1.80 ( ) < APC 1.00 (reference) - 1 APC 2.30 ( ) >2 APC 8.60 ( ) <0.001 Park et al JACC Cardiovasc Imaging 2015;8:1-10 Non-Obstructive lesions (<50%) Model 3 OR (95% CI) p Lumen area stenosis (per 5%) 1.30 ( ) 0.01 Lesion length 1.02 ( ) 0.44 PR 10.5 ( ) <0.001 LAP 1.30 ( ) 0.74 SC 1.80 ( ) 0.40 Model 4 Lumen area stenosis (per 5%) 1.30 ( ) 0.03 % APV (per 5%) 1.30 ( ) APC 1.00 (reference) - 1 APC 7.80 ( ) >2 APC 25.2 ( ) PR: positive remodeling, LAP: low attenuation plaque, SC: spotty calcification, %APV: percent aggregate plaque volume, APC: atherosclerotic plaque characteristic
25 CCTA and 5-year Risk of MI-The SCOT-HEART trial pts with stable chest pain Routine clinical Exercise test, stress imaging, CAG Routine clinical Exercise test, stress imaging, CAG R 1:1 Standard Care Standard Care +CCTA Median f-up 4.7 years (3-7) comprising pts/years Coronary Angio Coronary Revasc N Engl J Med 2018;379:924-33
26 CCTA and 5-year Risk of MI-The SCOT-HEART trial CAG beyond 1 year Cardiac death or non-fatal MI Standard care CCTA CCTA 2.3%vs3.9% HR 0.59 CI p=0.004 PCI beyond 1 year Non-fatal MI Standard care CCTA CCTA N Engl J Med 2018;379:924-33
27 Limitations The effect of plaque composition on mortality remains controversial. Imaging protocols, tube voltage settings, intracoronary contrast attenuation values, reconstruction algorithms filters and noise influence attenuation values. Remodeling is less conditional to image noise and having a more quantitative definition as the NRS might become a more robust marker. Even though CCTA is capable of identifying vulnerable markers witch correlate with pathology findings, we must focus on stenosis severity and overall plaque burden. Spotty calcification, positive remodeling and low attenuation
28 Prevalence and characteristics of TCFA and degree of stenosis STEMI 12%, NSTEMI 47% STABLE 41% 255pts, 643 plaques, 3vessel OCT Tian et al J Am Coll Cardiol 2014;64: The absolute number of TCFA is 3 times greater in non-severe stenosis. It is however, twice as likely for a lesion to be TCFA in cases of severe stenosis. Moreover TCFA in severely stenotic areas had more features of plaque vulnerability.
29 Low Prediction Risk limited number of events Annualized Risk of MI or CV death (%) PROSPECT STUDY High risk TCFA Intimal Thickening Rates are based on the occurrence of 6 MIs after 3.4 years of f-up among 1005 arterial sites with PIT and 595 TCFAs. Considering equal risk among the 3160 plaques detected at baseline (best case scenario) the event rate associated with each plaque is 0.06% per year. Stone et al, N Engl J Med 2011;364: Of 20 TCFAs only 5 remained unchanged (located proximally with and had large lumen areas), while 15 (75%) lost vulnerable characteristics. None of the 99 pts experienced any events during 1 year f-up. Thus many of the observed changes were likely the result of subclinical (silent) plaque ruptures. Kubo et al, J Am Coll Cardiol 2010;55:
30 Extend of plaque Disease and Adverse Events-CCTA study 3242 consecutive pts with a median f-up of 3.6 years Prediction of CV death or MI p< Annualized Risk of MI or CV Death (%) Global χ p< P= Non-obstructive limited Non-obstructive extensive Obstructive limited 10 0 Clinical probability Model 1 +CAD presence and severity Model 2 +CAD extend Bittencourt et al, Circ Cardiovasc Imaging 2014;7:282-91
31 Lessons from Pathology-260 with SCD PR TCFA FA The distribution of the extend of stenosis in TCFA and PR may suggest that the plaques that rupture are substantially narrowed at the time of an acute event, and it is rare to find disrupted but non-stenotic plaques. % Stenosis Narula et al. J Am Coll Cardiol 2013;61:
32 Plaque Vulnerability and Coronary Stenosis 0% Absolute number of plaque Absolute number of TCFA 50% Percentage of coronary stenosis Relative prevalence of TCFA High-risk TCFA 100% Patients with ACS, plaque ruptures are frequently found apart from culprit lesions, indicating that vulnerability is disseminated throughout the coronary tree. The absolute number of plaque and TCFA is greater in the area with mild stenosis. The relative prevalence of TCFA increases as the degree of coronary stenosis increases. Furthermore, TCFA at a higher degree of stenosis has more features of plaque vulnerability. Tian et al J Am Coll Cardiol 2014;64:
33 Thrombosis promoting factors Vascular thrombosis/acs Thrombosis promoting factors Vascular thrombosis/acs Fuster, J Am Coll Cardiol 2015;65: Thrombosis resting factors Asymptomatic plaque healing Thrombosis resting factors Asymptomatic plaque healing Most common scenario, small thrombus formation associated with plaque rupture is contained and vascular occlusive thrombus is inhibited Less common scenario of several prothrombotic factors coinciding (inflammatory state, large lesion plaque burden, vasoconstriction, circadian rheological changes) local thrombosis associated with plaque rupture cannot be contained, and clinically significant vascular thrombosis occur. The constellation of factors leading to these different outcomes is unknown.
34 Fusion Imaging Imaging modalities Lumen dimensions Plaque burden and positive remodeling Lipid component Cap thickness Neoangiogenesis Inflammation ESS Fast analysis IVUS + X-ray OCT + X-ray IVUS + CCTA OCT + CCTA NIRS-IVUS _ IVUS-OCT OCT-NIRF NK IVUS-NIRF NK OCT-NIRS NK IVUS-IVPA NK IVUS-FLIm NK Bourantas et al, Eurointervention 2017;38:400-12
35 Fusion Imaging
36 Conclusions Plaque ruptures and erosions are indeed responsible for most culprit lesions in patients with ACS. The frequency of subclinical plaque rupture is vastly underestimated and the assumption that identifying lesions prone to rupture will prevent ACS is unrealistic. Patients with high grade stenosis may carry an increased risk of death or MI since these lesions are markers for advanced disease in the coronary tree. Non obstructive and obstructive disease carry similar risk for death and MI if the former affects a larger number of arterial segments.
37 Conclusions Clinical imaging studies have not demonstrated improved risk prediction. Managing patients at risk of ACS mandates a greater focus on the disease burden rather than on features of individual plaques. This suggests that detection of a state of vulnerability in a patient is more important than detection of individual sites. Invasive and non-invasive imaging modalities provide such information to properly stratify patients at increased risk for cardiac events.
38 Thank you
Imaging Overview for Vulnerable Plaque: Data from IVUS Trial and An Introduction to VH-IVUS Imgaging
Imaging Overview for Vulnerable Plaque: Data from IVUS Trial and An Introduction to VH-IVUS Imgaging Gary S. Mintz,, MD Cardiovascular Research Foundation New York, NY Today, in reality, almost everything
More informationImaging Atheroma The quest for the Vulnerable Plaque
Imaging Atheroma The quest for the Vulnerable Plaque P.J. de Feijter 1. Department of Cardiology 2. Department of Radiology Coronary Heart Disease Remains the Leading Cause of Death in the U.S, Causing
More informationAdded Value of Invasive Coronary Imaging for Plaque Rupture and Erosion
Assessment of Coronary Plaque Rupture and Erosion Added Value of Invasive Coronary Imaging for Plaque Rupture and Erosion Yukio Ozaki, MD, PhD, FACC, FESC Cardiology Dept., Fujita Health Univ. Toyoake,
More informationThe PROSPECT Trial. A Natural History Study of Atherosclerosis Using Multimodality Intracoronary Imaging to Prospectively Identify Vulnerable Plaque
The PROSPECT Trial Providing Regional Observations to Study Predictors of Events in the Coronary Tree A Natural History Study of Atherosclerosis Using Multimodality Intracoronary Imaging to Prospectively
More informationCan IVUS Define Plaque Features that Impact Patient Care?
Can IVUS Define Plaque Features that Impact Patient Care? A Pichard L Satler, K Kent, R Waksman, W Suddath, N Bernardo, N Weissman, M Angelo, D Harrington, J Lindsay, J Panza. Washington Hospital Center
More informationAssessment of Vulnerable Plaque by IVUS and VH-IVUS
Assessment of Vulnerable Plaque by IVUS and VH-IVUS Akiko Maehara, MD Director of Intravascular Imaging & Physiology Core Laboratories Associate Director of MRI/MDCT Core Laboratory Cardiovascular Research
More informationCardiovascular Research Foundation and Columbia University Medical Center, New York.
Virtual Histology Intravascular Ultrasound Analysis of Non-culprit Attenuated Plaques Detected by Grayscale Intravascular Ultrasound in Patients with Acute Coronary Syndromes Xiaofan Wu, Akiko Maehara,
More informationInvasive Coronary Imaging Modalities for Vulnerable Plaque Detection
Invasive Coronary Imaging Modalities for Vulnerable Plaque Detection Gary S. Mintz, MD Cardiovascular Research Foundation New York, NY Greyscale IVUS studies have shown Plaque ruptures do not occur randomly
More informationPathology of Vulnerable Plaque Angioplasty Summit 2005 TCT Asia Pacific, Seoul, April 28-30, 2005
Pathology of Vulnerable Plaque Angioplasty Summit 25 TCT Asia Pacific, Seoul, April 28-3, 25 Renu Virmani, MD CVPath, A Research Service of the International Registry of Pathology Gaithersburg, MD Plaque
More informationHigh-risk vulnerable plaques. Kostis Raisakis G.Gennimatas General Hospital of Athens
High-risk vulnerable plaques. Kostis Raisakis G.Gennimatas General Hospital of Athens Overview: 1 Definition-Pathology 2 3 Diagnostic Strategies Invasive Non Invasive Prognostic Value of Detection 4 Treatment
More informationThe PROSPECT Trial. A Natural History Study of Atherosclerosis Using Multimodality Intracoronary Imaging to Prospectively Identify Vulnerable Plaque
The PROSPECT Trial Providing Regional Observations to Study Predictors of Events in the Coronary Tree A Natural History Study of Atherosclerosis Using Multimodality Intracoronary Imaging to Prospectively
More informationLeft main coronary artery (LMCA): The proximal segment
Anatomy and Pathology of Left main coronary artery G Nakazawa Tokai Univ. Kanagawa, Japan 1 Anatomy Difinition Left main coronary artery (LMCA): The proximal segment RCA AV LAD LM LCX of the left coronary
More information2yrs 2-6yrs >6yrs BMS 0% 22% 42% DES 29% 41% Nakazawa et al. J Am Coll Cardiol 2011;57:
Pathology of In-stent Neoatherosclerosis in BMS and DES 197 BMS, 103 SES, and 106 PES with implant duration >30 days The incidence of neoatherosclerosis was significantly greater in DES (31%) than BMS
More informationState of the Art. Advances in Cardiovascular Imaging. ESC Congres Stockholm September 1, 2010 Frank E. Rademakers, MD, PhD, FESC
State of the Art Advances in Cardiovascular Imaging ESC Congres Stockholm September 1, 2010 Frank E. Rademakers, MD, PhD, FESC Coronary Artery Disease Content Patho Physiology Imaging requirements Economical
More informationGary S. Mintz,, MD. IVUS Observations in Acute (vs Chronic) Coronary Artery Disease: Structure vs Function
Gary S. Mintz,, MD IVUS Observations in Acute (vs Chronic) Coronary Artery Disease: Structure vs Function Important IVUS Observations: Remodeling Originally used (first by Glagov) ) to explain atherosclerosis
More informationPathology of Coronary Artery Disease
Pathology of Coronary Artery Disease Seth J. Kligerman, MD Pathology of Coronary Artery Disease Seth Kligerman, MD Assistant Professor Medical Director of MRI University of Maryland Department of Radiology
More informationOptical Coherence Tomography for Intracoronary Imaging
Optical Coherence Tomography for Intracoronary Imaging Lorenz Räber Stephan Windecker Department of Cardiology Swiss Cardiovascular Center and Clinical Trials Unit Bern Bern University Hospital, Switzerland
More informationChapter 43 Noninvasive Coronary Plaque Imaging
hapter 43 Noninvasive oronary Plaque Imaging NIRUDH KOHLI The goal of coronary imaging is to define the extent of luminal narrowing as well as composition of an atherosclerotic plaque to facilitate appropriate
More informationCT Imaging of Atherosclerotic Plaque. William Stanford MD Professor-Emeritus Radiology University of Iowa College of Medicine Iowa City, IA
CT Imaging of Atherosclerotic Plaque William Stanford MD Professor-Emeritus Radiology University of Iowa College of Medicine Iowa City, IA PREVALENCE OF CARDIOVASCULAR DISEASE In 2006 there were 80 million
More informationOCT; Comparative Imaging Results with IVUS, VH and Angioscopy
OCT; Comparative Imaging Results with IVUS, VH and Angioscopy Takashi Akasaka, M.D. Department of Cardiovascular Medicine Wakayama, Japan Comparison among coronary imaging techniques OCT IVUS MRI CAG Angioscopy
More informationCottrell Memorial Lecture. Has Reversing Atherosclerosis Become the New Gold Standard in the Treatment of Cardiovascular Disease?
Cottrell Memorial Lecture Has Reversing Atherosclerosis Become the New Gold Standard in the Treatment of Cardiovascular Disease? Stephen Nicholls MBBS PhD @SAHMRI_Heart Disclosures Research support: AstraZeneca,
More informationVulnerable Plaque Pathophysiology, Detection, and Intervention. VP: A Local Problem or Systemic Disease. Erling Falk, Denmark
Vulnerable Plaque Pathophysiology, Detection, and Intervention VP: A Local Problem or Systemic Disease Erling Falk, Denmark Vulnerable Plaque Pathophysiology, Detection, and Intervention VP: A Local Problem
More informationFailure of positive. Recanalization and CTO formation. TCFA rupture with (fatal) thrombotic occlusion. TCFA Lipid pool
Vulnerable Plaque features on coronary CT Jin Ho Choi, MD, PhD Department of Internal Medicine, Emergency Medicine Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea IPS /
More informationAssessment of plaque morphology by OCT in patients with ACS
Assessment of plaque morphology by OCT in patients with ACS Takashi Akasaka, M.D. Department of Cardiovascular Medicine Wakayama, Japan Unstable plaque Intima Lipid core Plaque rupture and coronary events
More informationCan We Identify Vulnerable Patients & Vulnerable Plaque?
Can We Identify Vulnerable Patients & Vulnerable Plaque? We Know Enough to Treat High-Risk Lesions? Takashi Akasaka, MD, PhD Department of Cardiovascular Medicine, Japan Disclosure Statement of Financial
More informationCARDIAC IMAGING FOR SUBCLINICAL CAD
CARDIAC IMAGING FOR SUBCLINICAL CAD WHY DON'T YOU ADOPT MORE SMART TECHNIQUE? Whal Lee, M.D. Seoul National University Hospital Department of Radiology We are talking about Coronary artery Calcium scoring,
More informationCulprit Lesion Remodeling and Long-term (> 5years) Prognosis in Patients with Acute Coronary Syndrome
Culprit Lesion Remodeling and Long-term (> 5years) Prognosis in Patients with Acute Coronary Syndrome Hiroyuki Okura*, MD; Nobuya Matsushita**,MD Kenji Shimeno**, MD; Hiroyuki Yamaghishi**, MD Iku Toda**,
More informationOCT Findings: Lesson from Stable vs Unstable Plaques
ANGIOPLASTY SUMMIT TCTAP 2010 Imaging Workshop OCT Findings: Lesson from Stable vs Unstable Plaques Giulio Guagliumi MD Ospedali Riuniti di Bergamo, Italy DISCLOSURE OF FINANCIAL INTERESTS Consultant Boston
More informationΚλινική Χρήση IVUS και OCT PERIKLIS A. DAVLOUROS ASSOCIATE PROFESSOR OF CARDIOLOGY INVASIVE CARDIOLOGY & CONGENITAL HEART DISEASE
Κλινική Χρήση IVUS και OCT PERIKLIS A. DAVLOUROS ASSOCIATE PROFESSOR OF CARDIOLOGY INVASIVE CARDIOLOGY & CONGENITAL HEART DISEASE Conflict of interest None to declare While IVUS is the most used intravascular
More informationIVUS Analysis. Myeong-Ki. Hong, MD, PhD. Cardiac Center, Asan Medical Center University of Ulsan College of Medicine, Seoul, Korea
IVUS Analysis Myeong-Ki Hong, MD, PhD Cardiac Center, Asan Medical Center University of Ulsan College of Medicine, Seoul, Korea Intimal disease (plaque) is dense and will appear white Media is made of
More informationas a Mechanism of Stent Failure
In-Stent t Neoatherosclerosis e osc e os s as a Mechanism of Stent Failure Soo-Jin Kang MD., PhD. University of Ulsan College of Medicine, Heart Institute Asan Medical Center, Seoul, Korea Disclosure I
More informationCLINICAL APPLICATIONS OF OPTICAL COHERENCE TOMOGRAPHY. Konstantina P. Bouki, FESC 2 nd Department of Cardiology General Hospital Of Nikea, Pireaus
CLINICAL APPLICATIONS OF OPTICAL COHERENCE TOMOGRAPHY Konstantina P. Bouki, FESC 2 nd Department of Cardiology General Hospital Of Nikea, Pireaus OPTICAL COHERENCE TOMOGRAPHY (OCT) IVUS and OCT IVUS OCT
More information1st Department of Cardiology, University of Athens, Hippokration Hospital, Athens, Greece
Konstantinos Toutouzas, Maria Riga, Antonios Karanasos, Eleftherios Tsiamis, Andreas Synetos, Maria Drakopoulou, Chrysoula Patsa, Georgia Triantafyllou, Aris Androulakis, Christodoulos Stefanadis 1st Department
More informationFESC, FACC, MAHA, MSCAI, MEAPSI, ESH
«Απεικόνιση και φυσιολογία στο αιμοδυναμικό εργαστήριο». Eυάλωτη αθηρωματική πλάκα. Πού βρισκόμαστε? Ηλίας Α. Σανίδας MD, PhD, FESC, FACC, MAHA, MSCAI, MEAPSI, ESH Specialist Επεμβατικός Kαρδιολόγος Επιμελητής,
More informationNoninvasive Coronary Imaging: Plaque Imaging by MDCT
Coronary Physiology & Imaging Summit 2007 Noninvasive Coronary Imaging: Plaque Imaging by MDCT Byoung Wook Choi Department of Radiology Yonsei University, Seoul, Korea Stary, H. C. et al. Circulation
More informationIntervention: How and to which extent is technology helping us?
Cardiological Society of India Congress 12th February 2016 Chennai, India Intervention: How and to which extent is technology helping us? SIMONE BISCAGLIA MD CARDIOVASCULAR INSTITUTE, FERRARA, ITALY Introduction
More informationInvasive Evaluation of High Risk or Vulnerable Plaque A Powerful Tool to Address Potential Pharmacological Agents? Jagat Narula, MD PhD MACC
Invasive Evaluation of High Risk or Vulnerable Plaque A Powerful Tool to Address Potential Pharmacological Agents? Jagat Narula, MD PhD MACC No Conflicts of Interest to Declare Histological Signatures
More informationAmbiguity in Detection of Necrosis in IVUS Plaque Characterization Algorithms and SDH as Alternative Solution
Ambiguity in Detection of Necrosis in IVUS Plaque Characterization Algorithms and SDH as Alternative Solution Amin Katouzian, Ph.D., Debdoot Sheet, M.S., Abouzar Eslami, Ph.D., Athanasios Karamalis, M.Sc.,
More informationAssessment of vulnerable plaque by OCT
Assessment of vulnerable plaque by OCT Comparison with histology and possible clinical applications Takashi Akasaka, M.D. Department of Cardiovascular Medicine Wakayama, Japan Identification of vulnerable
More informationThe Dynamic Nature of Coronary Artery Lesion Morphology Assessed by Serial Virtual Histology Intravascular Ultrasound Tissue Characterization
Journal of the American College of Cardiology Vol. 55, No. 15, 2010 2010 by the American College of Cardiology Foundation ISSN 0735-1097/10/$36.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2009.07.078
More informationPost PCI functional testing and imaging: case based lessons from FFR React
Post PCI functional testing and imaging: case based lessons from FFR React Joost Daemen, MD, PhD, FESC Optics in Cardiology 2018 April 21st, 2018 10.15 10.30h Disclosure Statement of Financial Interest
More informationEAE Teaching Course. Magnetic Resonance Imaging. Competitive or Complementary? Sofia, Bulgaria, 5-7 April F.E. Rademakers
EAE Teaching Course Magnetic Resonance Imaging Competitive or Complementary? Sofia, Bulgaria, 5-7 April 2012 F.E. Rademakers Complementary? Of Course N Engl J Med 2012;366:54-63 Clinical relevance Treatment
More informationCardiac CT Angiography
Cardiac CT Angiography Dr James Chafey, Radiologist Why do we need a better test for C.A.D? 1. CAD is the leading cause of death in the US CAD 31% Cancer 23% Stroke 7% 2. The prevalence of atherosclerosis
More informationFrom the Vulnerable Atherosclerotic Plaque to CAD Management
33 rd Panhellenic Congress of Cardiology Athens, November 1-3, 2012 From the Vulnerable Atherosclerotic Plaque to CAD Management Filippos Triposkiadis, MD, FESC, FACC Professor of Cardiology Director,
More informationCoronary Artery Thermography
Coronary Artery Thermography The 10th Anniversary, Interventional Vascular Therapeutics Angioplasty Summit 2005 TCT Asia Pacific Christodoulos Stefanadis Professor of Cardiology Athens Medical School In
More informationLe espressioni della placca che preoccupano il clinico: progressione o vulnerabilità? CardioLUCCA Marzo 2017
Le espressioni della placca che preoccupano il clinico: progressione o vulnerabilità? CardioLUCCA Marzo 2017 F Prati San Giovanni H. and CLI Foundation, Rome Euro Image Research Che cosa preoccupa il cardiologo
More informationTissue Characterization of Coronary Plaques Using Intravascular Ultrasound/Virtual Histology
REVIEW Korean Circulation J 2006;36:553-558 ISSN 1738-5520 c 2006, The Korean Society of Circulation Tissue Characterization of Coronary Plaques Using Intravascular Ultrasound/Virtual Histology Jang-Ho
More informationQue nos puede aportar el OCT intracoronario
XXXI Jornadas SOLACI. 10ª Región CONOSUR LIIIº Congreso Chileno de Cardiología y Cirugía Cardiovascular Hotel Patagónico. Puerto Varas. Chile (30 Nov 1 Dic 2016) Que nos puede aportar el OCT intracoronario
More informationUsefulness of OCT during coronary intervention
Usefulness of OCT during coronary intervention Takashi Akasaka, M.D. Department of Cardiovascular Medicine Wakayama, Japan Predictors at 12 Months of Stent Thrombosis and Target Lesion Revascularization
More informationThe Future of intravascular Is there light or sound at the end of the tunnel? Hybrid Imaging
The Future of intravascular imaging : Is there light or sound at the end of the tunnel? Hybrid Imaging Jung Ho Heo MD, PhD Kosin University Hospital Busan, Korea From: A Heart With 67 Stents J Am Coll
More informationMultimodality Imaging Atlas of Coronary Atherosclerosis
JCC: CRDIOVSCUR IMGING VO. 3, NO. 8, 2010 2010 BY THE MERICN COEGE OF CRDIOOGY FOUNDTION ISSN 0735-1097/$36.00 PUBISHED BY ESEVIER INC. DOI:10.1016/j.jcmg.2010.06.006 IMGING VIGNETTE Multimodality Imaging
More informationDefining Plaque Composition by CTA: The Latest Tool to Monitor Therapy?
Defining Plaque Composition by CTA: The Latest Tool to Monitor Therapy? John McB. Hodgson, M.D., FSCAI Chairman, Department of Cardiology Geisinger Health System Wilkes Barre,, Pa Disclosure Information
More informationactually rupture! Challenges to the vulnerable plaque concept
An Update on the Pathogenesis of the Acute Coronary Syndromes Peter Libby Brigham & Women s Hospital Harvard Medical School ADVANCES IN HEART DISEASE University of California San Francisco December 20,
More informationPathology of the Vulnerable Plaque
Journal of the American College of Cardiology Vol. 47, No. 8 Suppl C 2006 by the American College of Cardiology Foundation ISSN 0735-1097/06/$32.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2005.10.065
More informationInsights in Thrombosis and In-Stent Restenosis
Clinical Value of OCT Insights in Thrombosis and In-Stent Restenosis Fernando Alfonso MD, PhD, FESC Interventional Cardiology. Cardiovascular Institute. Clinico San Carlos University Hospital. Madrid.
More informationYukio Ozaki, M Okumura, TF Ismail 2, S Motoyama, H. Naruse, K. Hattori, H. Kawai, M. Sarai, J. Ishii, Jagat Narula 3
Culprit Lesion Characteristics in Acute Coronary Syndrome and Stable Angina Assessed by Optical Coherence Tomography (OCT), Angioscopy, IVUS and Multidetector Computed Tomography (MDCT) Yukio Ozaki, M
More informationMR Imaging of Atherosclerotic Plaques
MR Imaging of Atherosclerotic Plaques Yeon Hyeon Choe, MD Department of Radiology, Samsung Medical Center, Sungkyunkwan University, Seoul MRI for Carotid Atheroma Excellent tissue contrast (fat, fibrous
More informationIschemic heart disease
Ischemic heart disease Introduction In > 90% of cases: the cause is: reduced coronary blood flow secondary to: obstructive atherosclerotic vascular disease so most of the time it is called: coronary artery
More informationTVA_C02.qxd 8/8/06 10:27 AM Page 19 PART 2. Pathology
TVA_C2.qxd 8/8/6 :27 AM Page 19 2 PART 2 Pathology TVA_C2.qxd 8/8/6 :27 AM Page TVA_C2.qxd 8/8/6 :27 AM Page 21 2 CHAPTER 2 The pathology of vulnerable plaque Renu Virmani, Allen P Burke, James T Willerson,
More informationCHAPTER (2) THE VULNERABLE PLAQUE
CHAPTER (2) THE VULNERABLE PLAQUE UNSTABLE OR HIGH RISK ATHEROSCLEROTIC PLAQUE - Definition and Composition - Plaque Destabilization and Disruption - Fate of Disrupted Plaque - Clinical Presentation -
More informationCoronary Artery Calcification
Coronary Artery Calcification Julianna M. Czum, MD OBJECTIVES CORONARY ARTERY CALCIFICATION Julianna M. Czum, MD Dartmouth-Hitchcock Medical Center 1. To review the clinical significance of coronary heart
More informationDynamic Nature of Nonculprit Coronary Artery Lesion Morphology in STEMI
JACC: CARDIOVASCULAR IMAGING VOL. 6, NO. 1, 2013 2013 BY THE AMERICAN COLLEGE OF CARDIOLOGY FOUNDATION ISSN 1936-878X/$36.00 PUBLISHED BY ELSEVIER INC. http://dx.doi.org/10.1016/j.jcmg.2012.08.010 Dynamic
More informationRESTENOSIS Facing up to the problem
RESTENOSIS Facing up to the problem Petr Kala University Hospital Brno Czech Republic ESC 2011, Paris Disclosure Scientific Advisory Boards or Education presentations fee Abbott, Boston Scientific, Cordis
More informationEvaluation of Intermediate Coronary lesions: Can You Handle the Pressure? Jeffrey A Southard, MD May 4, 2013
Evaluation of Intermediate Coronary lesions: Can You Handle the Pressure? Jeffrey A Southard, MD May 4, 2013 Disclosures Consultant- St Jude Medical Boston Scientific Speaker- Volcano Corporation Heart
More informationVascular disease. Structural evaluation of vascular disease. Goo-Yeong Cho, MD, PhD Seoul National University Bundang Hospital
Vascular disease. Structural evaluation of vascular disease Goo-Yeong Cho, MD, PhD Seoul National University Bundang Hospital resistance vessels : arteries
More informationIntegrating IVUS, FFR, and Noninvasive Imaging to Optimize Outcomes. Gary S. Mintz, MD Cardiovascular Research Foundation
Integrating IVUS, FFR, and Noninvasive Imaging to Optimize Outcomes Gary S. Mintz, MD Cardiovascular Research Foundation COURAGE Nuclear Substudy (n=314) Death/MI according the residual ischemia (SPECT)
More informationBetween Coronary Angiography and Fractional Flow Reserve
Visual-Functional Mismatch Between Coronary Angiography and Fractional Flow Reserve Seung-Jung Park, MD., PhD. University of Ulsan, College of Medicine Asan Medical Center, Seoul, Korea Visual - Functional
More informationMedical sciences 1 (2017) 1 9
Medical sciences 1 (2017) 1 9 TISSUE CHARACTERISTICS OF CULPRIT CORONARY LESIONS IN ACUTE CORONARY SYNDROME AND TARGET CORONARY LESIONS IN STABLE ANGINA PECTORIS: VIRTUAL HISTOLOGY AND INTRAVASCULAR ULTRASOUND
More informationImaging the Vulnerable Plaque. David A. Dowe, MD Atlantic Medical Imaging
Imaging the Vulnerable Plaque David A. Dowe, MD Atlantic Medical Imaging Why is this so important? The Acute Situation Coronary disease-important Diagnosis of cardiovascular disease cost $148 billion in
More informationIVUS Virtual Histology. Listening through Walls D. Geoffrey Vince, PhD The Cleveland Clinic Foundation
IVUS Virtual Histology Listening through Walls D. Geoffrey Vince, PhD Disclosure VH is licenced to Volcano Therapeutics Grant funding from Pfizer, Inc. Grant funding from Boston-Scientific Most Myocardial
More informationIntegrated Use of IVUS and FFR for LM Stenting
Integrated Use of IVUS and FFR for LM Stenting Gary S. Mintz, MD Cardiovascular Research Foundation Four studies have highlighted the inaccuracy of angiography in the assessment of LMCA disease Fisher
More informationDiagnostic and Prognostic Value of Coronary Ca Score
Diagnostic and Prognostic Value of Coronary Ca Score Dr. Ghormallah Alzahrani Cardiac imaging division, Adult Cardiology department Prince Sultan Cardiac Center ( PSCC) Madina, June 2 Coronary Calcium
More informationCatch-up Phenomenon: Insights from Pathology
Catch-up Phenomenon: Insights from Pathology Michael Joner, MD CVPath Institute Inc. Gaithersburg, MD USA Path Lessons learned from the BMS and DES (1 st Gen) era Neointimal Thickness [mm] In Stent Re
More informationMalaysian Healthy Ageing Society
Organised by: Co-Sponsored: Malaysian Healthy Ageing Society CAD INVESTIGATIONS PHYSIOLOGICAL / FUNCTIONAL VS ANATOMICAL / STRUCTURAL Disclosure iheal medical centre is a one stop cardiac centre with
More informationCombining Coronary Artery Calcium Scanning with SPECT/PET Myocardial Perfusion Imaging
Combining Coronary Artery Calcium Scanning with SPECT/PET Myocardial Perfusion Imaging Daniel S. Berman, MD Director, Cardiac Imaging Cedars-Sinai Heart Institute Professor of Medicine and Imaging Cedars-Sinai
More informationCPIS So-Yeon Choi, MD., PhD. Department of Cardiology Ajou University School of MedicineSuwon, Korea
So-Yeon Choi, MD., PhD. Department of Cardiology Ajou University School of MedicineSuwon, Korea Coronary Artery Imaging The ideal coronary imaging technology would be capable of identifying not only vessel
More informationOptical Coherence Tomography
Optical Coherence Tomography Disclosure Information Demetrius Lopes MD The following relationships exist related to this presentation: University Grant/Research Support: Rush University Industry Grant
More informationInvasive Imaging (IVUS, VH-IVUS, and OCT): How I Implement into My
Invasive Imaging (IVUS, VH-IVUS, and OCT): How I Implement into My Practice Gary S. Mintz, MD Cardiovascular Research Foundation Modalities FFR IVUS (with or without VH, imap, or IB-IVUS) OCT NIRS (with
More informationCoronary Artery Imaging. Suvipaporn Siripornpitak, MD Inter-hospital Conference : Rajavithi Hospital
Coronary Artery Imaging Suvipaporn Siripornpitak, MD Inter-hospital Conference : Rajavithi Hospital Larger array : cover scan area Detector size : spatial resolution Rotation speed : scan time Retrospective
More informationQuick guide. Core. precision guided therapy system
Quick guide Core precision guided therapy system The Philips Volcano imaging system should only be operated by trained personnel. The following information is presented for your convenience and is not
More informationControversies in Coronary Revascularization. Atlanta CCU April 15, 2016
Controversies in Coronary Revascularization Atlanta CCU April 15, 2016 Habib Samady MD FACC FSCAI Professor of Medicine Director, Interventional Cardiology, Emory University Director, Cardiac Catheterization
More informationFFR CT : Beyond FFR. Bon-Kwon Koo, MD, PhD. Seoul National University Hospital, Seoul, Korea. Seoul National University Hospital Cardiovascular Center
FFR CT : Beyond FFR Bon-Kwon Koo, MD, PhD, Seoul, Korea Patient-specific non-invasive coronary hemodynamic assessment Non-invasive, Pt-specific Hemodynamics Pressure Pressure difference Pressure gradient
More informationInnate Immunity in Atherosclerosis
Innate Immunity in Atherosclerosis Peter Libby Brigham & Women s Hospital Harvard Medical School IAS Amsterdam May 26, 2015 ACS Stable demand angina Characteristics of Atherosclerotic Plaques Associated
More informationOCT guidance for distal LM lesions
OCT guidance for distal LM lesions FRANCESCO BURZOTTA INSTITUTE OF CARDIOLOGY CATHOLIC UNIVERSITY OF THE SACRED HEART ROME, ITALY LM suitability for OCT At FU in stented LM Parodi G et al. Eurointervention
More informationTHE EFFECT OF CALCIFIED PLAQUE ON STRESS WITHIN A FIBROUS THIN CAP ATHEROMA IN AN ATHEROSCLEROTIC CORONARY ARTERY USING FINITE ELEMENT ANALYSIS (FEA)
THE EFFECT OF CALCIFIED PLAQUE ON STRESS WITHIN A FIBROUS THIN CAP ATHEROMA IN AN ATHEROSCLEROTIC CORONARY ARTERY USING FINITE ELEMENT ANALYSIS (FEA) A Thesis Presented to the Faculty of California Polytechnic
More informationThis review will reconsider the current paradigm for
Lessons From Sudden Coronary Death A Comprehensive Morphological Classification Scheme for Atherosclerotic Lesions Renu Virmani, Frank D. Kolodgie, Allen P. Burke, Andrew Farb, Stephen M. Schwartz This
More informationHead-to-Head Comparison of Coronary Plaque Evaluation Between Multislice Computed Tomography and Intravascular Ultrasound Radiofrequency Data Analysis
JACC: CARDIOVASCULAR INTERVENTIONS VOL. 1, NO. 2, 2008 2008 BY THE AMERICAN COLLEGE OF CARDIOLOGY FOUNDATION ISSN 1936-8798/08/$34.00 PUBLISHED BY ELSEVIER INC. DOI: 10.1016/j.jcin.2008.01.007 Head-to-Head
More informationSubclinical atherosclerosis in CVD: Risk stratification & management Raul Santos, MD
Subclinical atherosclerosis in CVD: Risk stratification & management Raul Santos, MD Sao Paulo Medical School Sao Paolo, Brazil Subclinical atherosclerosis in CVD risk: Stratification & management Prof.
More informationPCI for Left Anterior Descending Artery Ostial Stenosis
PCI for Left Anterior Descending Artery Ostial Stenosis Why do you hesitate PCI for LAD ostial stenosis? LAD Ostial Lesion Limitations of PCI High elastic recoil Involvement of the distal left main coronary
More information대한심장학회춘계학술대회 Satellite Symposium
대한심장학회춘계학술대회 Satellite Symposium Coronary Plaque Regression and Compositional Changes by Lipid-Lowering Therapy: IVUS Substudy in Livalo (Pitavastatin) in Acute Myocardial Infarction Study (LAMIS) Livalo
More informationCharacterization of coronary plaques with combined use of intravascular ultrasound, virtual histology and optical coherence tomography
Heart International 2010; volume 5:e12 Characterization of coronary plaques with combined use of intravascular ultrasound, virtual histology and optical coherence tomography Guillermo Sánchez-Elvira, 1
More informationOptical Coherence Tomography (OCT): A New Imaging Tool During Carotid Artery Stenting
Chapter 6 Optical Coherence Tomography (OCT): A New Imaging Tool During Carotid Artery Stenting Shinichi Yoshimura, Masanori Kawasaki, Kiyofumi Yamada, Arihiro Hattori, Kazuhiko Nishigaki, Shinya Minatoguchi
More informationNew Insight about FFR and IVUS MLA
New Insight about FFR and IVUS MLA Can IVUS MLA Predict FFR
More informationFFR and intravascular imaging, which of which?
FFR and intravascular imaging, which of which? Ayman Khairy MD, PhD, FESC Associate professor of Cardiovascular Medicine Vice Director of Assiut University Hospitals Assiut, Egypt Diagnostic assessment
More informationImpact of Body Mass Index and Metabolic Syndrome on the Characteristics of Coronary Plaques Using Computed Tomography Angiography
Impact of Body Mass Index and Metabolic Syndrome on the Characteristics of Coronary Plaques Using Computed Tomography Angiography Cardiovascular Division, Faculty of Medicine, University of Tsukuba Akira
More informationJose Mª de la Torre Hernandez, MD, PhD, FESC. Cardiologia Valdecilla Hospital Universitario Marques de Valdecilla Santander. SPAIN
Validation and application of IVUS-MLA in LMCA disease Jose Mª de la Torre Hernandez, MD, PhD, FESC Interventional Cardiology Dpt Cardiologia Valdecilla Hospital Universitario Marques de Valdecilla Santander.
More informationPlaque Imaging: What It Can Tell Us. Kenneth Snyder, MD, PhD L Nelson Hopkins MD FACS Elad Levy MD MBA FAHA FACS Adnan Siddiqui MD PhD
Plaque Imaging: What It Can Tell Us Kenneth Snyder, MD, PhD L Nelson Hopkins MD FACS Elad Levy MD MBA FAHA FACS Adnan Siddiqui MD PhD Buffalo Disclosure Information FINANCIAL DISCLOSURE: Research and consultant
More informationIntravascular Ultrasound
May 2008 Beth Israel Deaconess Medical Center Harvard Medical School Intravascular Ultrasound Matthew Altman, HMS III Gillian Lieberman, MD BIDMC Department of Radiology Presentation Overview 1. Patient
More informationHistopathology: Vascular pathology
Histopathology: Vascular pathology These presentations are to help you identify basic histopathological features. They do not contain the additional factual information that you need to learn about these
More informationIVUS vs FFR Debate: IVUS-Guided PCI
IVUS vs FFR Debate: IVUS-Guided PCI Gary S. Mintz, MD Cardiovascular Research Foundation New York, NY Disclosure Statement of Financial Interest Within the past 12 months, I have had a financial interest/arrangement
More information